###### Strengths and limitations of this study

-   This is the first study to investigate the prevalence of people admitted to hospital because of any foot-related condition within a representative inpatient population.

-   This study investigated inpatients from five different hospitals considered to be representative of inpatient populations in Australia.

-   Data collectors had specific training and high accuracy in collecting standard self-reported medical history and clinically diagnosed foot-related condition variables.

-   As a point-prevalence study, findings are reliant on the days surveyed being representative of standard activity and are unable to determine causal relationships.

Introduction {#s1}
============

Foot-related conditions can cause high burdens of disease due to high rates of hospitalisation and amputation.[@R1] In the context of hospitalisation, foot-related conditions typically refer to foot disease or foot trauma.[@R1] Foot disease typically refers collectively to ulcers, infections, ischaemia and Charcot foot and is usually precipitated by the foot risk factors of peripheral arterial disease (PAD), neuropathy and deformity.[@R1] [@R10] Foot trauma typically refers to limb-threatening injuries to the foot caused by high energy trauma.[@R8] [@R9]

Foot-related conditions have been reported to be present in considerable proportions of specific inpatient populations.[@R1] Yet, recent reviews conclude the direct foot-related inpatient burden has yet to be studied; that is, the total prevalence of all hospitalisations caused by any foot-related condition within a representative inpatient population.[@R1] [@R2] One large retrospective study of a national hospital discharge data set reported that 1.2% of all hospitalisations were caused by foot disease; however, it did not report foot trauma.[@R5] Therefore, there is a distinct gap in information to quantify the direct inpatient burden caused by foot-related conditions.[@R1] [@R2] Without this information, it is difficult for clinicians, researchers and policymakers to comprehend, compare and address a burden of disease.[@R13]

Thus, the primary aim of this point-prevalence study was to investigate a representative inpatient population to determine the prevalence of people admitted to hospital for the primary or secondary reason of a foot-related condition. A secondary aim was to investigate the independent factors associated with being admitted to hospital for the reason of a foot-related condition.

Methods {#s2}
=======

Study design {#s2a}
------------

This study was the first in the *Foot Disease in Inpatients Study (FDIS)* research project. The main objective of FDIS was to investigate the prevalence, and associated factors, of different foot disease disorders and foot risk factors in a representative inpatient population. This was a multisite observational point-prevalence cross-sectional study set in five public hospitals in Queensland, Australia. The authors have adhered to the STROBE reporting checklist for cross-sectional studies (see online [supplementary table](#SM1){ref-type="supplementary-material"} S1). Site-specific authority was also obtained from each hospital, and written informed consent was voluntarily obtained from all participants.
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Settings {#s2b}
--------

Five public hospitals made up the sites for this study: (1) a major metropolitan hospital (\>500 beds) with a catchment population of 900 000 in south Queensland; (2) major metropolitan specialty (\>500 beds) with a catchment population of 900 000 in south Queensland; (3) major regional (200--500 beds) with a catchment population of 220 000 in central Queensland; (4) large metropolitan (200--500 beds) with a catchment population of 250 000 in south Queensland and (5) large regional hospital (50--99 beds) with a catchment population of 30 000 in north Queensland. These hospitals were purposively selected by the authors to maximise the population-based generalisability of any findings by representing each of the different defined categories of peer group hospitals in Australia according to the National Health Performance Authority:[@R14] major metropolitan, major regional, large metropolitan, large regional and medium hospitals.[@R14] Specialist hospitals are unable to be defined into these peer groups;[@R14] thus, the authors decided to include a major metropolitan specialist hospital instead of a medium hospital to further maximise generalisability.

As a point-prevalence study, each hospital had data collected on one day. Practical resource implications meant the same day could not be chosen for all hospitals. After consultation with senior hospital management, a mid-week day (Tuesday to Thursday) was considered to be most representative of standard hospital activity. The designated day for each hospital was decided by the authors according to resource, travel and data collector availability. Data collection days for hospitals in similar regions were separated by 2 months to minimise the possibility of the same participant admission being captured twice. Data collection days were in 2013: major metropolitan (September), major metropolitan specialty (July), major regional (June), large metropolitan (December) and large regional hospital (June).

Participants {#s2c}
------------

Eligible participants were all adult inpatients (\>18 years) present between 8:00 and 17:00 in the hospital on the designated data collection day. An inpatient was defined as a person admitted for at least one night of hospital care for any reason, either the night prior or the night of the designated data collection day as confirmed by the treating medical officer. Exclusion criteria included those \<18 years of age; those with a cognitive deficit as determined by the Nurse Unit Manager; or those in a paediatric, maternity or psychiatric ward. These criteria are typical of point-prevalence inpatient studies.[@R15]

Sample size calculation {#s2d}
-----------------------

An inpatient prevalence of 4.6% was chosen as the basis for the sample size calculation.[@R1] This was chosen as a recent systematic review reported that foot wounds had been the most investigated of all inpatient foot-related conditions and 4.6% was the reported pooled prevalence estimate for inpatient foot wounds from this review.[@R1] Therefore, a sample size of 750 participants was calculated for this study based on an inpatient prevalence of 4.6%, a 95% CI of 3.1% to 6.1%, and an α level of 0.05.

Data collection instrument {#s2e}
--------------------------

A Queensland Foot Disease Form (QFDF) data collection instrument was used to collect all variables ([figure 1](#BMJOPEN2015010811F1){ref-type="fig"}). The QFDF was modified from a similar validated data collection instrument, the Queensland High Risk Foot Form (QHRFF).[@R19] In brief, the QHRFF collects 46 items via self-reported history and clinical diagnoses of foot-related conditions.[@R19] [@R20] Modifications to the QHRFF to develop the QFDF included enacting any changes recommended by its original authors;[@R19] removing variables not applicable to this study and adding variables identified from recent systematic reviews to be applicable to foot-related conditions in inpatients[@R1] [@R2] [@R21] such as reason for admission.[@R1] [@R5] [@R22] The 57-item QFDF contained 36 (78%) of the 46 items that were extensively tested for reliability and validity in the QHRFF.[@R19] The authors decided to further test the QFDF by testing the accuracy of data collectors using the QFDF against simulated cases, and testing the concurrent validity of a subsample of study data collected using the QFDF compared with medical records audited for the same data. Both testing procedures are described below.

![QFDF data collection instrument. CKD, chronic kidney disease; CVA, cardiovascular accident; ESKD, end-stage kidney disease; GP, general practitioner; HbA1c, glycated haemoglobin; MI, myocardial infarct; PAD, peripheral arterial disease; QFDF, Queensland Foot Disease Form; UTWCS, University of Texas Wound Classification System.](bmjopen2015010811f01){#BMJOPEN2015010811F1}

Variables collected {#s2f}
-------------------

[Table 1](#BMJOPEN2015010811TB1){ref-type="table"} outlines the criteria, definitions and supporting citations[@R5] [@R8] [@R19] used for each individual variable collected by the QFDF in this study. Patient explanatory variables were self-reported and grouped into ward, demographic, social determinant, medical condition history, self-care ability, past foot treatment and foot disease history variables. Foot explanatory variables were clinically diagnosed and grouped into foot risk factors, foot disease and foot risk status. The outcome variable of interest for this study was the self-reported identification of a foot-related condition as the participant\'s primary or secondary reason for admission. From those participants reporting a foot-related condition as a reason for admission, the foot explanatory variable considered to most likely have caused the admission was identified and termed the predominant foot-related condition causing admission. Trained data collectors administered all variables.

###### 

Definitions for each item of the QFDF

  QFDF item                           Definition
  ----------------------------------- ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Ward                                
   Surgical ward                      Participant is in a ward for the purpose of a surgical procedure[@R23]
   Medical ward                       Participant is in a ward not for the purpose of a surgical procedure[@R23]
  Demographics                        
   Age                                Participant\'s age in whole years at time of data collection[@R19] [@R21] [@R23] [@R24]
   Sex                                Participant is male, female or other[@R19] [@R21] [@R23] [@R24]
  Social determinants                 
   Socioeconomic status               Participant\'s postcode of usual residence was used to determine Australian Index of Relative Social Disadvantage status[@R21] [@R25]
   Geographical remoteness            Participant\'s postcode of usual residence was used to determine Accessibility/Remoteness Index of Australia status[@R21] [@R26]
   Highest education level achieved   What is the highest education qualification level you have achieved?[@R21] [@R24] [@R27]
   Born overseas                      In which country were you born?[@R24] [@R27]
   Indigenous status                  Are you of Aboriginal or Torres Strait Islander origin?[@R19] [@R23] [@R24]
  Medical condition history           
   Diabetes                           Have you ever been told by a doctor or nurse that you have had diabetes? (Should have lasted or likely to last for 6+ months)[@R19] [@R21] [@R24] [@R27] [@R28]
   Diabetes type                      If yes to diabetes, which type of diabetes do you have: type 1 or type 2?[@R19] [@R21] [@R24] [@R28]
   Hypertension                       Have you ever been told by a doctor or nurse that you have had hypertension or high blood pressure? (Should have lasted or likely to last for 6+ months)[@R19] [@R24] [@R27]
   Dyslipidaemia                      Have you ever been told by a doctor or nurse that you have had dyslipidaemia or high cholesterol? (Should have lasted or likely to last for 6+ months)[@R19] [@R24]
   MI                                 Have you ever been told by a doctor or nurse that you have had MI or heart attack? (Should have lasted or likely to last for 6+ months)[@R19] [@R21] [@R24]
   CVA                                Have you ever been told by a doctor or nurse that you have had cardiovascular attack or stroke? (Should have lasted or likely to last for 6+ months)[@R19] [@R21] [@R24] [@R27]
   CKD                                Have you ever been told by a doctor or nurse that you have had CKD? (Should have lasted or likely to last for 6+ months)[@R19] [@R21]
   ESKD                               Have you ever been told by a doctor or nurse that you have had kidney failure or do you need dialysis? (Should have lasted or likely to last for 6+ months)[@R19]
   Cancer                             Have you ever been told by a doctor or nurse that you have had cancer? (Should have lasted or likely to last for 6+ months)[@R21] [@R27]
   Arthritis                          Have you ever been told by a doctor or nurse that you have had arthritis? (Should have lasted or likely to last for 6+ months)[@R27]
   Depression                         Have you ever been told by a doctor or nurse that you have had depression? (Should have lasted or likely to last for 6+ months)[@R24] [@R27]
   Acute foot trauma                  Have you had major trauma to your feet that resulted in a fracture, burn, wound or infection that required hospital treatment?[@R8] [@R9]
   Smoker                             Are you a current smoker?[@R19] [@R21] [@R24] [@R27]
   Ex-smoker                          If no to smoker, did you ever smoke?[@R19] [@R21] [@R24] [@R27]
  Self-care ability                   
   Mobility impairment                Are you able to walk without the help of an aide?[@R11] [@R21]
   Vision impairment                  Are you able to read a newspaper (with glasses if needed)[@R11] [@R21]
   Footwear worn: inside              From a sheet displaying 16 different types of footwear: What is the type of shoes you have worn most inside the house over the past 12 months?[@R21] [@R29] [@R30]
   Footwear worn: outside             From a sheet displaying 16 different types of footwear: What is the type of shoes you have worn most outside the house over the past 12 months?[@R21] [@R29] [@R30]
   Low-risk footwear                  Participant identified picture of walking shoe, runner, oxford shoe, boot or bespoke footwear as footwear worn most[@R29] [@R30]
   Moderate-risk footwear             Participant identified picture of moccasin, ugg boot, slipper or backless slipper as footwear worn most[@R29] [@R30]
   High-risk footwear                 Participant identified picture of high heels, flip flop, court shoe, mule or sandal as footwear worn most[@R29] [@R30]
   No footwear worn                   Participant identified picture of socks only or barefoot as footwear worn most[@R29] [@R30]
  Past foot treatment                 
   Yes                                Have you been treated for a foot problem in the past 12 months? (Excluding in the current admission)[@R19] [@R31]
   Podiatry                           Have you been treated for a foot problem by a podiatrist in the past 12 months? (Excluding in the current admission)[@R19] [@R31]
   GP                                 Have you been treated for a foot problem by a GP in the past 12 months? (Excluding in the current admission)[@R19] [@R31]
   Physician                          Have you been treated for a foot problem by another medical physician in the past 12 months? (Excluding in the current admission)[@R19] [@R31]
   Surgeon                            Have you been treated for a foot problem by a surgeon in the past 12 months? (Excluding in the current admission)[@R19] [@R31]
   Nurse                              Have you been treated for a foot problem by a nurse in the past 12 months? (Excluding in the current admission)[@R19] [@R31]
   Orthotist                          Have you been treated for a foot problem by an orthotist in the past 12 months? (Excluding in the current admission)[@R19] [@R31]
   Other                              Have you been treated for a foot problem by any other health professional/s in the past 12 months? (Excluding in the current admission)[@R19] [@R31]
  Foot disease history                
   Previous PN                        Have you ever been told by a doctor or nurse that you have had PN? (Should have lasted or likely to last for 6+ months)[@R19]
   Previous PAD                       Have you ever been told by a doctor or nurse that you have had PAD? (Should have lasted or likely to last for 6+ months)[@R19] [@R21]
   Previous foot ulcer                Have you ever had a foot ulcer that has healed?[@R19] [@R21]
   Previous amputation                Have you ever had an amputation? Plus, a clinical examination to verify previous healed lower extremity amputation site[@R19] [@R21]
   Foot risk factors                  
   PN                                 A lack of protective sensation to a 10 g monofilament on at least 2 of 3 plantar forefoot locations on at least one foot[@R11] [@R19] [@R28] [@R32] [@R33]
   PAD                                Absence of at least one palpable foot pulse and a toe systolic pressure \<70 mm Hg on at least one foot[@R10] [@R19] [@R33]
   Mild PAD                           Toe systolic pressure=51--70 mm Hg[@R10] [@R19] [@R33]
   Moderate PAD                       Toe systolic pressure=31--50 mm Hg[@R10] [@R19] [@R35] [@R36]
   Critical PAD (ischaemia)           Toe systolic pressure=\<30 mm Hg[@R10] [@R19] [@R33] [@R35]
   Foot deformity                     A score of at least 3 using the 6-point foot deformity score on at least one foot (1 point each allocated for small muscle wastage, bony prominence, prominent metatarsal heads, hammer/claw toes, limited joint mobility and Charcot deformity)[@R19] [@R29] [@R32]
  Foot disease                        
   Acute Charcot                      A red, hot, swollen, unilateral neuropathic foot without a local foot wound on at least one foot[@R19] [@R28] [@R32]
   Current foot ulcer                 Do you have a current foot ulcer or sore? Plus, a clinical examination to verify a full thickness wound beneath the ankle[@R19] [@R37]
   Current foot infection             At least 2 manifestations of inflammation beneath the ankle (purulence, erythema, pain, tenderness, warmth or induration)[@R19] [@R33] [@R38] [@R39]
  Foot risk status                    
   Low risk                           Nil foot disease history or clinical diagnosis of current foot disease, PN or PAD identified during the clinical examination[@R19] [@R32]
   At risk                            Clinical diagnosis of PN and/or PAD (excluding critical PAD) identified during the clinical examination[@R19] [@R32]
   High risk                          Clinical diagnosis of critical PAD, or, foot deformity with PN and/or PAD, or, self-reported previous foot ulcer or amputation[@R19] [@R32]
   Acute                              Current foot wound or acute Charcot[@R19] [@R32]
  Foot-related condition admission    
   Primary reason for admission       Is a foot condition the main reason for your hospital admission?[@R5] [@R20] [@R22] [@R23]
   Secondary reason for admission     Is a foot condition another reason for your hospital admission?[@R5] [@R22] [@R23]

CKD, chronic kidney disease; CVA, cardiovascular accident; ESKD, end-stage kidney disease; GP, general practitioner; MI, myocardial infarct; PAD, peripheral arterial disease; PN, peripheral neuropathy; QFDF,Queensland Foot Disease Form.

Data collection procedure {#s2g}
-------------------------

### Data collector training {#s2g1}

Data collectors were 27 publicly employed podiatrists who routinely used the QHRFF in their existing clinical practice. Data collectors were assisted by 25 final year undergraduate podiatry students and 4 publicly employed other staff. The role of the assistants was to help the data collectors with administering the consenting and self-reported history processes only. All data collectors and assistants participated in a 3-hour training session \<1 month prior to their designated data collection day.

### Data collector testing {#s2g2}

All data collectors were tested on their use of the 57-item QFDF, using simulated cases to assess their data collection accuracy immediately pretraining and post-training session. A minimum of 80% accuracy on the 57-item simulated cases was required to be endorsed as a data collector and differences in pretraining and post-training scores were analysed.

### Data collection {#s2g3}

Data collection occurred between 8:00 and 17:00 on the designated day. Data collection teams of up to eight people were allocated up to five wards of potentially eligible participants for data collection. After completing the voluntary consenting procedure, included participants were questioned to determine their self-report history variables. Participants were then shown a footwear form (modified with permission from Barton *et al*[@R30]) containing 16 footwear styles to identify their main footwear worn inside and outside the house in the previous 12 months. All participants then underwent a non-invasive physical examination by a data collector to determine their clinically diagnosed variables. All participant data were recorded on the QFDF and all completed QFDF data collection forms were checked at the conclusion of each hospital data collection day by the authors for errors or omissions. Any missing data or potential data errors were clarified with the data collector concerned.

### Data collector audit {#s2g4}

As aforementioned, a subsample of data collected from participants (study data) was tested for concurrent validity with the participants\' medical records (medical records). As the study was conducted in different regions, a random sample was unable to be tested due to resource constraints. Therefore, to be representative of the different wards and hospitals in the study, a subsample (∼5% of the required study sample size) was taken from one general medical and one general surgical ward located in the large metropolitan hospital, which was the third largest (middle-sized) hospital. The process for the audit involved first collecting the study data from the subsample of participants as per the data collection procedure. The hospital medical records of those participants included in the subsample were then audited on the same day by two authors who were blinded to the subsample study data collected. The authors were instructed to review the medical record and complete all applicable variables if noted anywhere in the medical record using a QFDF. The applicable variables recorded from the medical records were then compared with the study data collected for agreement.

Statistical analysis {#s2h}
--------------------

All data were analysed using SPSS V.22.0 for Windows (SPSS, Chicago, Illinois, USA) or GraphPad Software. Descriptive statistics were used to display all variables, using means and SDs for continuous variables or proportions for categorical variables. Prevalence with 95% CIs were calculated using a modified Wald method for outcome variables.[@R40] χ^2^ or Kruskal-Wallis tests were used to test differences between hospitals for categorical variables and t-tests or analysis of variance to test differences between hospitals for continuous variables.[@R41] Univariate logistic regression analyses were undertaken to test for crude associations with the outcomes.[@R41]

Multivariate logistic regression was used to analyse for independent associations.[@R42] [@R43] As this study was investigating a new field, a data-driven backwards stepwise method was chosen.[@R42] [@R43] All variables achieving crude associations (p\<0.2), except those deemed illogical, were entered into the backwards stepwise model, non-significant variables (p\>0.05) were removed at each step, until only variables achieving statistical significance remained (p\<0.05) and their ORs reported (unadjusted model).[@R42] [@R43] This model method was consistent with similar foot-related studies.[@R31] [@R36] [@R44] Collinearity was tested for all models using correlation matrix (\>0.9), tolerance (\<0.1) and variance inflation factor (\>10).[@R42] [@R43] If collinearity was identified, the variable with the lowest OR in the univariate analysis was removed. The Hosmer and Lemeshow goodness of fit, Omnibus and Negelkerke pseudo R^2^ tests were used at each step of all models to indicate goodness of fit, significance, parsimony and potential variance of the outcome variable explained by the model, respectively.[@R42] [@R43] The final unadjusted model was then tested for confounding by re-entering in each non-included explanatory variable to see if it confounded the independent explanatory variables in the unadjusted model.[@R42] [@R43] A confounder was defined, and remained in the model, as changing the β effect estimates of at least one unadjusted independent explanatory variables by \>20% (adjusted model).[@R42] Two different multivariate models were assessed for each outcome variable. The first used all available explanatory variables, except the summarised foot risk status variable (model 1). The second used the summarised foot risk status variable, instead of foot disease history, foot risk factors and foot disease explanatory variables (model 2). Missing data were treated by excluding cases with missing data as missing data were minimal (\<5% in all models).[@R42]

Lastly, κ for dichotomous variables, weighted κ (wK) for ordinal variables and intraclass correlation (ICC; models 2 and 1) for continuous variables were used to test for measures of agreement for the data collector testing and audit.[@R41] [@R47] [@R48] κ and wK (SEs ) strengths were categorised as: no agreement \<0; slight agreement=0--0.20; fair agreement=0.21--0.40; moderate agreement=0.41--0.6; substantial agreement=0.61--0.8 and near-perfect agreement=0.81--1.0.[@R41] [@R47] [@R48] ICC (SD) strengths were categorised as: weak--moderate agreement \<0.75 and strong agreement \>0.75.[@R41]

Results {#s3}
=======

Characteristics {#s3a}
---------------

Online [supplementary table](#SM1){ref-type="supplementary-material"} S2 reports the demographic characteristics of the 1146 total inpatients present during the study. Of these, 263 (23%) patients were non-eligible and excluded: 248 due to cognitive impairment and 15 for other reasons (including children, non-English speaking or unavailable). Non-eligible patients were older (p\<0.001) with no differences in sex (p=0.717). Of the 883 eligible patients, 733 (83%) consented. There were no differences in age (p=0.187) or sex (p=0.198) between those consenting and non-consenting.

[Table 2](#BMJOPEN2015010811TB2){ref-type="table"} reports the characteristics of the 733 included participants. Overall, mean age (SD) was 62.0 (18.6) years and 55.8% were males. Differences were evident between hospitals for demographic, social determinant, medical history, self-care ability, past foot treatment, foot disease history and foot risk status variables (p\<0.05). No differences between hospitals were recorded for foot risk factor and foot disease variables (p\<0.05).

###### 

Participant characteristics for each hospital site (number (%) unless otherwise stated)

                                              n     Total                      Large regional   Major regional   Large Metro   Major Metro specialty   Major Metro. general   p Value
  ------------------------------------------- ----- -------------------------- ---------------- ---------------- ------------- ----------------------- ---------------------- -----------
  Participants                                733   733                        21               82               90            232                     308                    
  Ward                                                                                                                                                                        
   Medical                                    733   459 (62.6%)                16 (76.2%)       49 (59.8%)       57 (63.3%)    171 (73.7%)             166 (53.9%)            
   Surgical                                   733   274 (37.4%)                5 (23.8%)        33 (40.2%)       33 (36.7%)    61 (26.3%)              142 (46.1%)            \<0.001\*
  Demographics                                                                                                                                                                
   Age (SD) years                             731   62.0 (18.6)                50.0 (18.0)\*    63.5 (19.1)      63.2 (18.3)   65.5 (18.3)             59.5 (18.3)\*          \<0.001\*
   Age range years                            731   18--99                     20--85           18--91           21--96        18--99                  18--94                 
   Age groups                                 731                                                                                                                             
    18--40 years                                    110 (15.0%)                6 (28.6%)        12 (14.6%)       12 (13.3%)    28 (12.1%)              52 (16.9%)             
    41--60 years                                    188 (25.7%)                8 (38.1%)        20 (24.4%)       23 (25.6%)    54 (23.4%)              83 (27.0%)             
    61--80 years                                    316 (43.2%)                6 (28.6%)        36 (43.9%)       37 (41.1%)    94 (40.7%)              143 (46.6%)            
    81+ years                                       117 (16.0%)                1 (4.8%)         14 (17.1%)       18 (20.0%)    55 (23.8%)              29 (9.4%)              \<0.001\*
   Male sex                                   731   408 (55.8%)                13 (61.9%)       52 (63.4%)       46 (51.1%)    127 (54.7%)             170 (55.6%)            0.531
  Social determinants                                                                                                                                                         
   Socioeconomic status                       711                                                                                                                             
    Most disadvantaged                              102 (14.3%)                6 (28.6%)        4 (5.1%)         30 (34.1%)    23 (10.2%)              39 (13.1%)             
    Second most disadvantaged                       159 (22.4%)                2 (9.5%)         41 (51.9%)       40 (45.5%)    27 (11.9%)              49 (16.5%)             
    Middle                                          98 (13.8%)                 12 (57.1%)       27 (34.2%)       10 (11.4%)    22 (9.7%)               27 (9.1%)              
    Second least disadvantaged                      240 (33.8%)                1 (4.8%)         5 (6.3%)         8 (9.1%)      131 (58.0%)             95 (32.0%)             
    Least disadvantaged                             112 (15.8%)                0                2 (2.5%)         0             23 (10.2%)              87 (29.3%)             \<0.001\*
   Geographic remoteness                      711                                                                                                                             
    Major city                                      435 (61.2%)                1 (4.8%)         1 (1.3%)         54 (61.4%)    179 (79.2%)             200 (67.3%)            
    Inner regional area                             153 (21.5%)                0                40 (50.6%)       26 (29.5%)    36 (15.9%)              51 (17.2%)             
    Outer regional area                             66 (9.3%)                  1 (4.8%)         21 (26.6%)       8 (9.1%)      5 (2.2%)                31 (10.4%)             
    Remote area                                     30 (4.2%)                  2 (9.5%)         13 (16.5%)       0             5 (2.2%)                10 (2.4%)              
    Very remote area                                27 (3.8%)                  17 (81.0%)       4 (5.1%)         0             1 (0.4%)                5 (1.7%)               \<0.001\*
   Highest education level                    731                              21               82               90            230                     308                    
    Year 10 and under                               395 (54.0%)                14 (66.7%)       58 (70.7%)       54 (60.0%)    124 (53.9%)             145 (47.1%)            
    Year 12                                         132 (18.1%)                3 (14.3%)        9 (11.0%)        18 (20.0%)    38 (16.5%)              64 (20.8%)             
    Certificate in trade or business                74 (10.1%)                 2 (9.5%)         9 (11.0%)        10 (11.1%)    25 (10.9%)              28 (9.1%)              
    Diploma or associate degree                     46 (6.3%)                  0                5 (6.1%)         5 (5.6%)      17 (7.4%)               19 (6.2%)              
    Bachelor degree                                 48 (6.6%)                  0                0                1 (1.1%)      12 (5.2%)               35 (11.4%)             
    Graduate diploma or certificate                 15 (2.1%)                  1 (4.8%)         0                2 (2.2%)      6 (2.6%)                6 (1.9%)               
    Postgraduate degree                             18 (2.5%)                  1 (4.8%)         1 (1.2%)         0             7 (3.0%)                9 (2.9%)               
    Other                                           3 (0.4%)                   0                0                0             1 (0.4%)                2 (0.6%)               \<0.001\*
   Born overseas                              731   161 (22.0%)                2 (9.5%)         11 (13.4%)       20 (22.5%)    53 (22.8%)              75 (24.4%)             0.159
   Indigenous                                 732   34 (4.6%)                  10 (47.6%)       5 (6.1%)         3 (3.4%)      8 (3.4%)                8 (2.6%)               \<0.001\*
  Medical condition history                                                                                                                                                   
   Diabetes                                   733   172 (23.5%)                6 (28.6%)        20 (24.4%)       18 (20.0%)    66 (28.4%)              62 (20.1%)             0.195
   Type 2 diabetes†                                 162 (22.1%)                6 (28.6%)        20 (24.4%)       18 (20.0%)    59 (25.4%)              59 (19.2%)             0.139
   Hypertension                               733   359 (49.0%)                11 (52.4%)       40 (48.8%)       52 (57.8%)    129 (55.6%)             127 (41.2%)            0.006\*
   Dyslipidaemia                              733   234 (31.9%)                6 (28.6%)        30 (36.6%)       34 (37.8%)    91 (39.2%)              73 (23.7%)             0.001\*
   Myocardial infarct                         733   146 (19.9%)                4 (19.0%)        10 (12.2%)       18 (20.0%)    67 (28.9%)              47 (15.3%)             0.001\*
   Cerebrovascular accident                   733   85 (11.6%)                 1 (4.8%)         10 (12.2%)       10 (11.1%)    36 (15.5%)              28 (9.1%)              0.173
   Chronic kidney disease                     733   89 (12.1%)                 1 (4.8%)         9 (11.0%)        15 (16.7%)    31 (13.4%)              33 (10.7%)             0.431
   End-stage kidney disease†                  733   9 (1.2%)                   0                3 (3.7%)         1 (1.1%)      0                       5 (1.6%)               NA
   Cancer                                     733   174 (23.7%)                1 (4.8%)         19 (23.2%)       26 (28.9%)    43 (18.5%)              85 (27.6%)             0.021\*
   Arthritis                                  733   274 (37.4%)                5 (23.8%)        36 (44.4%)       40 (44.4%)    91 (39.2%)              102 (33.1%)            0.100
   Depression                                 733   191 (26.1%)                2 (9.5%)         29 (35.4%)       28 (31.1%)    55 (23.7%)              77 (25.0%)             0.069
   Acute foot trauma                          733   26 (3.5%)                  1 (4.8%)         4 (4.9%)         6 (6.7%)      2 (0.9%)                13 (4.2%)              0.079
   Smoker                                     733   104 (14.2%)                7 (33.3%)        18 (22.0%)       17 (18.9%)    12 (5.2%)               50 (16.2%)             \<0.001\*
   Ex-smoker                                  733   304 (41.5%)                10 (47.6%)       34 (41.5%)       35 (38.9%)    109 (47.0%)             116 (37.7%)            0.256
  Self-care ability                                                                                                                                                           
   Mobility impairment                        729   242 (33.2%)                4 (19.0%)        36 (43.9%)       37 (41.1%)    78 (33.8%)              87 (28.5%)             0.020\*
   Vision impairment                          730   110 (15.1%)                2 (9.5%)         10 (12.2%)       12 (13.5%)    41 (17.7%)              45 (14.7%)             0.637
   Footwear worn: inside                      728                                                                                                                             
    Low-risk footwear                               81 (11.1%)                 0                9 (11.0%)        5 (5.6%)      29 (12.7%)              38 (12.4%)             
    Moderate-risk footwear                          263 (36.1%)                2 (9.5%)         35 (42.7%)       28 (31.1%)    108 (47.2%)             90 (29.4%)             
    High-risk footwear                              139 (19.1%)                11 (52.4%)       12 (14.6%)       17 (18.9%)    33 (14.4%)              66 (21.6%)             
    No footwear worn                                245 (33.7%)                8 (38.1%)        26 (31.7%)       40 (44.4%)    59 (25.8%)              112 (36.6%)            \<0.001\*
   Footwear worn: outside                     726                                                                                                                             
    Low-risk footwear                               386 (53.2%)                12 (57.1%)       46 (56.1%)       50 (55.6%)    118 (51.5%)             160 (52.6%)            
    Moderate-risk footwear                          75 (10.3%)                 1 (4.8%)         8 (9.8%)         10 (11.1%)    34 (14.8%)              22 (7.2%)              
    High-risk footwear                              250 (34.4%)                8 (38.1%)        26 (31.7%)       29 (32.2%)    74 (32.3%)              113 (37.2%)            
    No footwear worn                                15 (2.1%)                  0                2 (2.4%)         1 (1.1%)      3 (1.3%)                9 (3.0%)               0.405
  Past foot treatment                         733                                                                                                                             
   Yes                                              256 (34.9%)                6 (28.6%)        38 (46.3)        31 (34.4%)    83 (35.8%)              98 (31.8%)             0.167
   Podiatrist                                       180 (24.6%)                4 (19.0%)        21 (25.6%)       23 (25.6%)    70 (30.2%)              62 (20.1%)             0.105
   GP                                               93 (12.7%)                 3 (14.3%)        22 (26.8%)       8 (8.9%)      19 (8.2%)               41 (13.3%)             \<0.001\*
   Surgeon                                          36 (4.9%)                  0                6 (7.3%)         2 (2.2%)      6 (2.6%)                22 (7.1%)              0.050
   Physician                                        21 (2.9%)                  2 (9.5%)         7 (8.5%)         0             4 (1.7%)                8 (2.6%)               0.002\*
   Nurse                                            20 (2.7%)                  1 (4.8%)         3 (3.7%)         0             6 (2.6%)                10 (3.2%)              0.486
   Orthotist                                        4 (0.5%)                   0                1 (1.2%)         1 (1.1%)      0                       2 (0.6%)               NA
   Other                                            9 (1.2%)                   3 (14)           0                1 (1.1%)      0                       5 (1.6%)               NA
  Foot disease history                                                                                                                                                        
   Previous peripheral neuropathy             728   99 (13.6%)                 0                9 (11.0%)        13 (14.4%)    20 (8.7%)               57 (18.8%)             0.004\*
   Previous PAD                               728   97 (13.3%)                 1 (4.8%)         7 (8.5%)         13 (14.4%)    17 (7.4%)               59 (19.4%)             0.001\*
   Previous foot ulcer                        731   72 (9.8%)                  1 (4.8%)         6 (7.3%)         9 (10.0%)     17 (7.4%)               39 (12.7%)             0.228
   Previous amputation                        731   30 (4.1%)                  0                2 (2.4%)         3 (3.3%)      6 (2.6%)                19 (6.2%)              0.181
  Foot risk factors                                                                                                                                                           
   Peripheral neuropathy                      728   160 (22.0%)                3 (14.3%)        24 (29.6%)       16 (17.8%)    58 (25.1%)              59 (19.3%)             0.137
   PAD                                        728                                                                                                                             
    Mild PAD                                        69 (9.5%)                  2 (9.5%)         7 (8.5%)         8 (8.9%)      25 (10.8%)              27 (8.9%)              
    Moderate PAD                                    51 (7.0%)                  0                5 (6.1%)         7 (7.8%)      18 (7.8%)               21 (6.9%)              
    Critical PAD                                    33 (4.5%)                  1 (4.8%)         2 (2.4%)         3 (3.3%)      8 (3.5%)                19 (6.3%)              0.887
   Foot deformity                             706   158 (22.4%)                2 (9.5%)         13 (16.0%)       20 (22.7%)    51 (22.5%)              72 (24.9%)             0.293
  Foot disease                                                                                                                                                                
   Acute Charcot                              730   2 (0.3%)                   0                0                0             2 (0.9%)                0                      NA
   Current foot ulcer                         732   46 (6.3%)                  0                6 (7.3%)         5 (5.6%)      10 (4.3%)               25 (8.1%)              0.298
   Current foot infection                     723   24 (3.3%)                  0                5 (6.2%)         3 (3.3%)      5 (2.2%)                11 (3.6%)              0.405
  Foot risk status                            731                                                                                                                             
   Low risk                                         445 (60.9%)                15 (71.4%)       43 (52.4%)       59 (65.6%)    132 (57.1%)             196 (63.8%)            
   At risk                                          111 (15.2%)                1 (4.8%)         20 (24.4%)       9 (10.0%)     50 (21.6%)              31 (10.1%)             
   High risk                                        109 (14.9%)                4 (19.0%)        8 (9.8%)         16 (17.8%)    37 (16.0%)              44 (14.4%)             
   Acute                                            66 (9.0%)                  1 (4.8%)         11 (13.4%)       6 (6.7%)      12 (5.2%)               36 (11.7%)             0.001\*
  Foot-related condition admission (95% CI)   732   82 (11.2%) (9.1 to 13.7)   1 (4.8%)         13 (15.9%)       6 (6.7%)      14 (6.0%)               48 (15.6%)             0.002\*
   Primary reason (95% CI)                    732   54 (7.4%) (5.7 to 9.5)     1 (4.8%)         10 (12.2%)       5 (5.6%)      5 (2.2%)                33 (10.7%)             0.002\*
   Secondary reason (95% CI)                  732   28 (3.8%) (2.6 to 5.5)     0                3 (3.7%)         1 (1.1%)      9 (3.9%)                15 (4.9%)              NA

\*p Value of \<0.05.

†Numbers also included in overall condition. GP, general practitioner; Metro, metropolitan; NA, not applicable to test as the assumption of χ^2^ test is violated as two cells had expected count \<5; PAD, peripheral arterial disease.

Prevalence {#s3b}
----------

Primary reason for admission for foot-related conditions were identified in 54 participants (7.4% (95% CI 5.7% to 9.5%)) and 15 of those had diabetes (2.0% (1.2% to 3.4%); [table 2](#BMJOPEN2015010811TB2){ref-type="table"}). The predominant causes of these were foot disease in 36 participants (4.9% (3.6% to 6.7%); 17 foot infection, 13 critical PAD, 6 foot ulcer), foot trauma in 15 participants (2.1% (1.2% to 3.4%)) and 3 others were unable to be determined with the variables collected. Higher proportions of primary foot-related admissions existed in the major regional (12.2%) and major metropolitan general hospitals (10.7%) as compared with the other hospitals (p\<0.05).

Secondary reason for admission for foot-related conditions were identified in 28 participants (3.8% (2.6% to 5.5%)) and 19 of those had diabetes (2.6% (1.6% to 4.0%); [table 2](#BMJOPEN2015010811TB2){ref-type="table"}). The predominant causes of these were foot disease in 13 participants (1.8% (1.0% to 3.0%); 9 foot ulcers, 3 foot infections, 1 critical PAD), foot trauma in 1 (0.1% (0% to 0.8%)) and 14 others were unable to be determined. No differences in proportions of secondary foot-related admissions between hospitals were identified.

Independent associated factors {#s3c}
------------------------------

[Table 3](#BMJOPEN2015010811TB3){ref-type="table"} reports unadjusted and adjusted OR (95% CIs) for variables achieving significance for primary reason for admission for foot-related conditions. Univariate analyses (p\<0.2) identified 20 variables eligible for model 1 and 12 for model 2 (see online [supplementary table](#SM1){ref-type="supplementary-material"} S3). Current foot ulcer was excluded as collinearity was identified with current foot infection. Model 1 identified six unadjusted independent associated factors: critical PAD, current foot infection, acute foot trauma, past surgeon treatment, past general practitioner (GP) treatment and myocardial infarct (MI) history (all p\<0.05). Identified confounders were: socioeconomic status, diabetes, chronic kidney disease (CKD) and dyslipidaemia. After adjusting, all factors remained significant (all p\<0.01), except MI (p\>0.2). Model 2 identified four unadjusted independent associated factors: acute foot risk status, high foot risk status, past surgeon treatment and past GP treatment (all p\<0.05). Identified confounders were: diabetes, MI, CKD, acute foot trauma and past podiatry treatment. After adjusting, all factors remained significant (all p\<0.001).

###### 

Independent associated factors for primary admissions for foot-related conditions using multivariate logistical regression (ORs (95% CI))

  Risk factor               Unadjusted                                       p Value                              Adjusted                                          p Value
  ------------------------- ------------------------------------------------ ------------------------------------ ------------------------------------------------- ------------------------------------
  Model 1                                                                                                                                                           
   Myocardial infarct       0.15 (0.03 to 0.70)                              0.016\*                              0.34 (0.06 to 1.90)                               0.219
   Acute foot trauma        29.49 (7.28 to 119.48)                           \<0.001\*                            73.32 (15.86 to 338.92)                           \<0.001\*
   PAD                                                                       \<0.001\*                                                                              \<0.001\*
   Nil PAD                  Referent                                                                              Referent                                          
   Mild PAD                 0                                                NA                                   0                                                 NA
   Moderate PAD             2.37 (0.62 to 9.04)                              0.207                                5.45 (1.05 to 28.23)                              0.044
   Critical PAD             53.60 (16.82 to 170.84)                          \<0.001\*                            140.56 (30.82 to 641.04)                          \<0.001\*
   Current foot infection   29.39 (7.52 to 114.83)                           \<0.001\*                            53.11 (9.89 to 285.17)                            \<0.001\*
   Past GP treatment        4.65 (1.64 to 13.20)                             0.004\*                              7.61 (2.30 to 25.19)                              0.001\*
   Past surgeon treatment   5.88 (1.66 to 20.81)                             0.006\*                              6.98 (1.91 to 25.54)                              0.003\*
  * Model 1 results:*       *Pseudo R^2^: 0.602; Omnibus: df=8, p=\<0.001*   *Missing: 14 (1.9%); H&L: p=0.013*   *Pseudo R^2^: 0.657; Omnibus: df=15, p=\<0.001*   *Missing: 36 (4.9%); H&L: p=0.880*
  Model 2                   \+ Past foot treatment                                                                                                                  
   Foot risk status                                                          \<0.001\*                                                                              \<0.001\*
   Low risk                 Referent                                                                              Referent                                          
   At risk                  1.66 (0.15 to 18.76)                             0.682                                2.01 (0.18 to 23.16)                              0.574
   High risk                23.12 (5.05 to 105.95)                           \<0.001\*                            39.57 (8.15 to 192.05)                            \<0.001\*
   Acute                    181.44 (40.52 to 812.51)                         \<0.001\*                            158.63 (30.34 to 829.51)                          \<0.001\*
   Past GP treatment        2.70 (1.17 to 6.25)                              0.020\*                              6.40 (2.36 to 17.40)                              \<0.001\*
   Past surgeon treatment   4.31 (1.49 to 12.44)                             0.007\*                              11.62 (3.46 to 39.03)                             \<0.001\*
  * Model 2 results:*       *Pseudo R^2^: 0.582; Omnibus: df=5, p=\<0.001*   *Missing: 2 (0.3%); H&L: p=0.861*    *Pseudo R^2^: 0.638; Omnibus: df=10, p=\<0.001*   *Missing: 2 (0.3%); H&L: p=0.954*

\*p\<0.05.df, degrees of freedom; H&L, Hosmer and Lemeshow test; missing, excluded missing cases; NA, not applicable; Omnibus, Omnibus tests of model coefficients; Pseudo R^2^, Nagelkerke R^2^; GP, general practitioner; PAD, peripheral arterial disease.

[Table 4](#BMJOPEN2015010811TB4){ref-type="table"} reports unadjusted and adjusted OR (95% CIs) for variables achieving significance for secondary reason for admission for foot-related conditions. Univariate analyses (p\<0.2) identified 16 variables eligible for model 1 and 10 for model 2 (see online [supplementary table](#SM1){ref-type="supplementary-material"} S3). Current foot infection was excluded as collinearity was identified with current foot ulcer. Model 1 identified two unadjusted independent associated factors: diabetes and current foot ulcer (both p\<0.001). Identified confounders were: mobility impairment and previous foot ulcer. After adjusting, both factors remained significant (both p\<0.01). Model 2 identified two unadjusted independent associated factors: diabetes and acute foot risk status (both p\<0.001). No adjustment was performed as no confounders were identified.

###### 

Independent associated factors for secondary admissions for foot-related conditions using multivariate logistical regression (ORs (95% CI))

  Risk factor           Unadjusted                                       p Value                             Adjusted                                         p Value
  --------------------- ------------------------------------------------ ----------------------------------- ------------------------------------------------ -----------------------------------
  Model 1                                                                                                                                                     
   Diabetes             5.46 (2.33 to 12.78)                             \<0.001\*                           4.89 (2.07 to 11.57)                             \<0.001\*
   Current foot ulcer   9.84 (4.13 to 23.45)                             \<0.001\*                           4.94 (2.12 to 16.67)                             0.001\*
  * Model 1 results:*   *Pseudo R^2^: 0.233; Omnibus: df=2, p=\<0.001*   *Missing: 1 (0.1%); H&L: p=0.755*   *Pseudo R^2^: 0.259; Omnibus: df=4, p=\<0.001*   *Missing: 5 (0.7%); H&L: p=0.425*
  Model 2                                                                                                                                                     
   Diabetes             5.27 (2.23 to 12.45)                             \<0.001\*                           No confounders identified                        
   Foot risk status                                                      \<0.001\*                                                                            
   Low risk             Referent                                                                                                                              
   At risk              2.19 (0.56 to 8.55)                              0.258                                                                                
   High risk            2.81 (0.78 to 10.18)                             0.116                                                                                
   Acute                16.12 (5.40 to 48.11)                            \<0.001\*                                                                            
  * Model 2 results:*   *Pseudo R^2^: 0.261; Omnibus: df=4, p=\<0.001*   *Missing: 2 (0.3%); H&L: p=0.680*                                                    

\*p\<0.05.

df, degrees of freedom; H&L, Hosmer and Lemeshow test; missing, excluded missing cases; NA, not applicable; Omnibus, Omnibus tests of model coefficients; Pseudo R^2^, Nagelkerke R^2^.

Data collector testing and audit results {#s3d}
----------------------------------------

Online [supplementary table](#SM1){ref-type="supplementary-material"} S4 reports an improvement in the data collectors post-training scores compared with pretraining scores (p\<0.001). All participants scored \>90% in the post-test. Online [supplementary table](#SM1){ref-type="supplementary-material"} S5 reports the strengths of agreement between the study data and medical records data for the 44 eligible and 28 consenting participants in the subsample. Of the 19 applicable variables tested, 12 (63%) had near-perfect/strong, 2 (11%) substantial, 3 (16%) moderate and 2 (11%) had fair agreement. In variables reporting less than near-perfect/strong agreement, study data identified more cases than medical records.

Discussion {#s4}
==========

Principal findings {#s4a}
------------------

We believe this is the first study to investigate the direct inpatient burden caused by all foot-related conditions within a representative inpatient population. Our findings indicate 7.4% of all inpatients were hospitalised for the primary reason of a foot-related condition, including 4.9% for foot disease and 2.1% foot trauma. Interestingly, only 28% of those had diabetes. An additional 3.8% were hospitalised with a foot-related condition as a secondary reason for admission, including 1.8% for foot disease and 0.1% for foot trauma. Being admitted for the primary reason of a foot-related condition was independently associated with having critical PAD, foot infection, foot trauma or past foot treatment by a surgeon or GP. Whereas, being admitted for a secondary reason of a foot-related condition was independently associated with having diabetes or a current foot ulcer. Overall, these findings suggest the direct inpatient burden caused by foot-related conditions is significantly higher than previously reported, affecting 1 in 13 inpatients with the majority not related to diabetes.

Interpretations of findings {#s4b}
---------------------------

The large disparity between our 7.4% direct foot-related inpatient burden finding and the 1.2% in the only previous similar study[@R5] may be explained by a number of methodological differences. The previous study retrospectively investigated foot disease codes only from a standard hospital discharge data set to identify patients,[@R5] compared with our study which prospectively examined for all possible foot-related conditions. Yet, our study still reported a much higher rate for those hospitalised for foot disease (4.9%) compared with the previous study (1.2%).[@R5] Retrospective analyses compared with prospective examinations have been found to under-report foot-related admissions in the same Australian inpatient population by threefold.[@R12] Additionally, the previous study investigated hospital admissions,[@R5] whereas our study investigated a one occupied hospital bed day period. Foot-related admissions use threefold the number of bed days than average hospital admissions in Australia.[@R3] [@R6] These methodological improvements compared with the previous study suggest our findings are plausible and much higher than previously reported.

We found only 28% of foot-related hospitalisations were in people with diabetes which was similar to the 15% reported in the previous study.[@R5] This suggests the majority of the inpatient foot-related burden may not be caused by diabetes as has been traditionally considered.[@R3] [@R4] Our findings equate to 2.0% of all inpatients, on a given day, being in hospital because of diabetes-related foot disease in Queensland. Considering a recent retrospective study of the Queensland hospital discharge data set identified that 0.9% of all hospital bed days in Queensland were primarily used to manage diabetes-related foot disease,[@R6] and the under-reporting in retrospective studies,[@R12] our findings again seem plausible. Our findings also appear generalisable when interpreting diabetes rate trends between ours and other regions. The 23.5% inpatient diabetes prevalence found in our Queensland study is similar to the 24.7% reported in Victoria (Australia),[@R17] 26.2% in the USA,[@R49] [@R50] but higher than 15.8% in the UK.[@R51] The diagnosed diabetes population prevalence in Queensland is 4.5% and 5.0% in Victoria;[@R52] while the estimated national diabetes population prevalence for Australia is 7.8%, 9.2% in the USA and 4.9% in the UK.[@R53] Also diabetes-related amputation rates, often used as a surrogate measure of the foot disease burden, showed similar trends with 15 per 100 000 people reported in Queensland,[@R6] 18 in Australia, 36 in the USA and 9 in the UK.[@R54] [@R55] These interpretations suggest our findings are plausible and potentially generalisable to other regions.

Our study also found that nearly all those primarily hospitalised for a foot-related condition were due to foot disease (67%) or foot trauma (28%). These findings were supported by our multivariate models reporting they were independantly associated with a foot disease disorder (critical PAD, foot infection or foot ulceration), foot trauma or had previous foot treatment from a GP or surgeon. These same independent associates have been consistently identified in diabetes inpatient populations;[@R10] [@R11] [@R37] [@R38] however, our findings adjusted for diabetes in a representative inpatient population. Furthermore, after adjustment, inpatients classified with acute foot risk status were much more likely to be in hospital for the primary reason of a foot-related condition than those of lower foot risk status. This suggests, regardless of diabetes, that using a diabetes foot risk status system[@R19] [@R32] may be useful to identify people highly likely to be admitted to hospital because of a foot-related condition.

In addition to those primarily hospitalised for a foot-related condition, 3.8% of participants reported a foot-related condition as a secondary reason for their admission. This meant the participant had been primarily admitted for another health condition, yet also required treatment in hospital to manage a foot-related condition.[@R23] To the best of the authors\' knowledge, no study has investigated the prevalence of secondary foot-related admissions. Participants with a secondary foot-related condition were more likely to have diabetes or a current foot ulcer. This is not surprising considering people with diabetes have very high rates of foot-related conditions compared with other disease processes in the population.[@R1] [@R5] [@R7] Furthermore, those with a current foot ulcer typically require frequent wound dressing changes[@R4] [@R32] within the average length of hospital admission.[@R3] [@R5] [@R6] Overall, the primary and secondary reason for admission findings indicate that 11.2% of all inpatients need treatment for a foot-related condition during their hospitalisation.

The type of hospital and ward also appeared to impact on the prevalence of people admitted due to a foot-related condition. Our findings indicate major general hospitals have higher prevalences of people admitted with a foot-related condition than other hospital types. Those admitted with a foot-related condition as the primary reason were also more likely to be in a surgical ward, whereas those admitted as a secondary reason were mostly found in a medical ward. These findings may be explained by major general hospitals housing more of the necessary surgical disciplines needed to effectively manage complex foot-related conditions,[@R9] [@R32] and thus more of these patients being transferred to these hospitals. Although this study has focused on inpatient explanations, the impact of available outpatient services cannot be discounted.[@R6] This is especially the case considering recent significant reductions in diabetes-related foot disease admissions in Queensland were reportedly associated with improved outpatient multidisciplinary foot services.[@R6]

Implications for policymakers, clinicians and researchers {#s4c}
---------------------------------------------------------

Our findings have significant potential implications for policymakers. To contextualise these finding, an 'average' 600-bed hospital could expect to manage 44 inpatients each night for the primary reason of a foot-related condition, including 29 for foot disease and 13 for foot trauma. This equates to an annual direct cost of \$A15.6 million for an average hospital if assuming \$A971 (2015) per Australian hospital bed day.[@R56] Forecasting this across Australia\'s 49 153 public hospital beds[@R57] suggests Australia would need 3637 hospital beds each night, or 1.33 million beds each year, at an annual cost of \$A1.29 billion to primarily manage foot-related conditions. Assuming a conservative 13-day average length of stay for foot-related conditions[@R2] indicates Australia has over 102 000 annual primary admissions for foot-related conditions, including 67 600 for foot disease and 27 600 for foot trauma. With cellulitis ranked as the 10th leading cause of Australian public hospital admissions with 35 248 admissions,[@R58] these figures would place foot-related conditions in the top 10 causes of hospital admission in Australia. Interestingly, two-thirds of these reported cellulitis admissions were infections in the lower leg and foot.[@R58] These figures are likely to be conservative as they do not account for private hospitals, surgical procedures, secondary foot-related admissions and any other foot-related inpatient management.

These findings also suggest clinicians should focus their inpatient foot-related strategies on foot disease and foot trauma, regardless of diabetes. First, we recommend using a simple foot risk screening tool,[@R19] [@R32] or foot ulcer visual inspection, as admission triage strategies to improve identification of inpatient foot-related conditions. Like recent amputation prediction tools,[@R10] these tools could also be enhanced by including critical PAD in the acute foot category to further improve identification. Second, our findings indicate those people hospitalised for a foot-related condition had not previously attended the recommended outpatient multidisciplinary foot team members.[@R4] [@R6] [@R11] [@R32] Thus, we recommended all people with foot-related conditions have access to outpatient multidisciplinary foot teams, regardless of diabetes status. Third, our findings support other authors recommending episodes of foot-related hospitalisation should be an opportunity to triage inpatients into multidisciplinary foot teams for best practice care.[@R22] [@R28] [@R59] Last, it is suggested strategies already demonstrated to reduce the inpatient diabetic foot burden should be considered for all inpatients admitted for foot-related conditions, such as triaging foot-related admissions into specialist multidisciplinary foot wards.[@R4] [@R11] [@R28] [@R59]

Our findings also support further research. First, to confirm the findings of this study, we recommend implementing methodologically similar research in other regions.[@R1] [@R11] [@R59] Second, our findings support recommendations that hospital discharge data coders are trained to more accurately identify and code foot-related condition admissions to enable more effective monitoring of standard hospital discharge data sets.[@R1] [@R12] Third, we recommend reporting the use of occupied hospital bed days, rather than whole admissions, to more specifically measure the burden of hospitalisation. Fourth, the foot disease and foot trauma factors identified in this study should be investigated for 'up stream' factors that may predict these foot-related hospitalisations. Last, it is recommended that clinical trials implementing strategies demonstrated to reduce the inpatient diabetic foot disease burden should be evaluated on all inpatients admitted for foot-related conditions.

Strengths and weaknesses {#s4d}
------------------------

This study has several strengths. First, the study\'s findings are generalisable as we purposively investigated representative hospitals that reported very similar demographic, social determinant and medical history characteristics to those reported in other large inpatient studies.[@R17] [@R58] Second, this study recruited total participant numbers \<3% of the original sample size calculated, reported a robust consent rate \>80%,[@R18] and no differences in demographic characteristics between consenting and non-consenting inpatients. Third, the study used a data collection instrument modified from a very similar valid and reliable data collection instrument that captured a range of standard self-reported or clinically diagnosed foot-related variables.[@R19] Fourth, data collectors had previous similar data collection experience, further specific training and reported high accuracy and validity when tested against simulated cases and medical records. Last, the multivariate models used in this study were recommended to identify independent associated factors after adjusting for identified confounders and the sample size was large enough to account for over 50 variables.[@R42] [@R43]

This study also had a number of limitations. First, the study was cross-sectional and can only report on associated factors and not causal relationships.[@R41] Second, as a point-prevalence study, it relies on the day of data collection being representative of standard inpatient activity.[@R18] Third, while excluding cognitively impaired patients is standard,[@R15] this may have introduced a selection bias towards under-reporting foot-related conditions as excluded patients were mostly older cognitively impaired patients that have higher foot disease rates than cognitively intact patients.[@R60] Fourth, although standard self-reported medical history and clinically diagnosed foot-related variables were used, these were not gold standard biomedical criteria and may under-report medical conditions.[@R10] [@R17] [@R34] Fifth, while the study used a data collection instrument modified from an existing valid and reliable instrument, it was only retested against simulated cases and medical records, which limits our knowledge on its validity and reliability for capturing these data.[@R41] Last, as this study used over 100 statistical tests, there is the likelihood of a type 1 statistical error.[@R41]

Conclusions {#s5}
===========

This is the first study to investigate the burden caused by people admitted to hospital because of foot-related conditions within a representative inpatient population. Findings indicate the burden is significantly higher than previously reported with 1 in every 13 inpatients in hospital for the primary reason of a foot-related condition. These patients were mostly affected by foot disease or foot trauma, in major general hospitals and most did not have diabetes. It is recommended that serious consideration be given to future strategies to investigate and intervene in this considerable, yet historically underappreciated, inpatient burden.
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